Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12610)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 14, 2016 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nassir F, Ibdah JA. Sirtuins and nonalcoholic fatty liver disease. World J Gastroenterol 2016; 22(46): 10084-10092 [PMID: 28028356 DOI: 10.3748/wjg.v22.i46.10084] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i46/10084.htm |
| Number | Citing Articles |
| 1 |
Luo Yang, Xiang Zhang, Min Liao, Yarong Hao. RETRACTED: Echinacoside improves diabetic liver injury by regulating the AMPK/SIRT1 signaling pathway in db/db mice. Life Sciences 2021; 271: 119237 doi: 10.1016/j.lfs.2021.119237
|
| 2 |
William P. Esler, Kendra K. Bence. Metabolic Targets in Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2019; 8(2): 247 doi: 10.1016/j.jcmgh.2019.04.007
|
| 3 |
Jun-Ke Long, Wen Dai, Ya-Wen Zheng, Shui-Ping Zhao. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Molecular Medicine 2019; 25(1) doi: 10.1186/s10020-019-0085-2
|
| 4 |
Bei Yan, Lei Chen, Yanhui Wang, Jiacheng Zhang, Hui Zhao, Qinglian Hua, Shengjie Pei, Zihang Yue, Hui Liang, Huaqi Zhang. Preventive Effect of Apple Polyphenol Extract on High-Fat Diet-Induced Hepatic Steatosis in Mice through Alleviating Endoplasmic Reticulum Stress. Journal of Agricultural and Food Chemistry 2022; 70(10): 3172 doi: 10.1021/acs.jafc.1c07733
|
| 5 |
Jun Sung Moon, Jun Hwa Hong, Yong Jin Jung, Ele Ferrannini, Michael A. Nauck, Soo Lim. SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. Trends in Endocrinology & Metabolism 2022; 33(6): 424 doi: 10.1016/j.tem.2022.03.005
|
| 6 |
Karl Walter Bock. Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD). Biochemical Pharmacology 2020; 175: 113905 doi: 10.1016/j.bcp.2020.113905
|
| 7 |
Nicole E. De Long, Daniel B. Hardy, Noelle Ma, Alison C. Holloway. Increased incidence of non‐alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis. Journal of Applied Toxicology 2017; 37(12): 1507 doi: 10.1002/jat.3502
|
| 8 |
Shifeng Fu, Meihong Yu, Yuyong Tan, Deliang Liu. Role of histone deacetylase on nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(4): 353 doi: 10.1080/17474124.2021.1854089
|
| 9 |
Johanna Pedroza-Diaz, Johanna C. Arroyave-Ospina, Sandra Serna Salas, Han Moshage. Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease. Antioxidants 2022; 11(5): 975 doi: 10.3390/antiox11050975
|
| 10 |
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
|
| 11 |
Sérgio Henrique Sousa Santos, Victor Hugo Dantas Guimarães, Janaina Ribeiro Oliveira, Luiz Fernando Rezende. Sirtuin Biology in Cancer and Metabolic Disease. 2021; : 39 doi: 10.1016/B978-0-12-822467-0.00003-6
|
| 12 |
Alessandra Stacchiotti, Ilaria Grossi, Raquel García-Gómez, Gaurangkumar Patel, Alessandro Salvi, Antonio Lavazza, Giuseppina De Petro, Maria Monsalve, Rita Rezzani. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy. Cells 2019; 8(9): 1053 doi: 10.3390/cells8091053
|
| 13 |
Yu Wu, Xiaosheng Jin, Ya Zhang, Jian Liu, Mingjiang Wu, Haibin Tong. Bioactive Compounds from Brown Algae Alleviate Nonalcoholic Fatty Liver Disease: An Extensive Review. Journal of Agricultural and Food Chemistry 2023; 71(4): 1771 doi: 10.1021/acs.jafc.2c06578
|
| 14 |
Marco Moroldo, Peris Mumbi Munyaka, Jérôme Lecardonnel, Gaëtan Lemonnier, Eric Venturi, Claire Chevaleyre, Isabelle P. Oswald, Jordi Estellé, Claire Rogel-Gaillard. Integrative analysis of blood and gut microbiota data suggests a non-alcoholic fatty liver disease (NAFLD)-related disorder in French SLAdd minipigs. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-019-57127-x
|
| 15 |
Devaraj Ezhilarasan. Deciphering the toxicological role of Porphyromonas gingivalis derived endotoxins in liver diseases. Environmental Toxicology and Pharmacology 2021; 88: 103755 doi: 10.1016/j.etap.2021.103755
|
| 16 |
Béatrice Morio, Baptiste Panthu, Arthur Bassot, Jennifer Rieusset. Role of mitochondria in liver metabolic health and diseases. Cell Calcium 2021; 94: 102336 doi: 10.1016/j.ceca.2020.102336
|
| 17 |
Lang Shen, Lijia Xie, Li Chen, Li Liu, Xiao Shi, Xiaocong Wang, Donghong Chen, Hui Wang, Song Quan, Zhijian Wang. Resveratrol reverses the programmed high-susceptibility to non-alcoholic fatty liver disease by targeting the hepatic SIRT1-SREBP1c pathway in prenatal ethanol-exposed rat offspring. The Journal of Toxicological Sciences 2021; 46(9): 413 doi: 10.2131/jts.46.413
|
| 18 |
Karl Walter Bock. Aryl hydrocarbon receptor (AHR)-mediated inflammation and resolution: Non-genomic and genomic signaling. Biochemical Pharmacology 2020; 182: 114220 doi: 10.1016/j.bcp.2020.114220
|
| 19 |
Chao-Yue Sun, Zuo-Liang Zheng, Cun-Wu Chen, Bao-Wei Lu, Dong Liu. Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.859206
|
| 20 |
Daeun Lee, Ye-Ram Kim, Jae-Sung Kim, Donggyu Kim, Sojin Kim, Sun Young Kim, Kiseok Jang, Jong-Dae Lee, Chul-Su Yang. Dietary schizophyllan reduces mitochondrial damage by activating SIRT3 in mice. Archives of Pharmacal Research 2020; 43(4): 449 doi: 10.1007/s12272-020-01231-4
|
| 21 |
D. Osipova, K. Kokoreva, L. Lazebnik, E. Golovanova, Ch. Pavlov, A. Dukhanin, S. Orlova, K. Starostin. Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.797923
|
| 22 |
Soo-Jin Lee, Sung-E Choi, Seokho Park, Yoonjung Hwang, Youngho Son, Yup Kang. CD38 Inhibition Protects Fructose-Induced Toxicity in Primary Hepatocytes. Molecules and Cells 2023; 46(8): 496 doi: 10.14348/molcells.2023.0045
|
| 23 |
Komal Thapa, Ajmer Singh Grewal, Neha Kanojia, Lata Rani, Neelam Sharma, Sukhbir Singh. Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. Current Drug Discovery Technologies 2021; 18(3): 333 doi: 10.2174/1570163817666200121143959
|
| 24 |
Zheng Li, Yan Li, Hui‐Xia Zhang, Jian‐Ru Guo, Christopher Wai Kei Lam, Cai‐Yun Wang, Wei Zhang. Mitochondria‐Mediated Pathogenesis and Therapeutics for Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research 2019; 63(16) doi: 10.1002/mnfr.201900043
|
| 25 |
Zeynab Yousefi, Mitra Nourbakhsh, Zohreh Abdolvahabi, Seyedeh‐Sara Ghorbanhosseini, Zahra Hesari, Sahar Yarahmadi, Samira Ezzati‐Mobasser, Parvane Seiri, Mohammad Borji, Reza Meshkani, Mojtaba Malek. microRNA‐141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP‐activated protein kinase pathway in hepatocytes. Journal of Cellular Physiology 2020; 235(2): 880 doi: 10.1002/jcp.29002
|
| 26 |
Mao-Meng Tiao, Yu-Ju Lin, Hong-Ren Yu, Jiunn-Ming Sheen, I-Chun Lin, Yun-Ju Lai, You-Lin Tain, Li-Tung Huang, Ching-Chou Tsai. Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0824-3
|
| 27 |
Hao Han, Jie Li, Lei Tian, Liyuan Pei, Mingming Zheng. Through regulation of the SIRT1 pathway plant sterol ester of α-linolenic acid inhibits pyroptosis thereby attenuating the development of NASH in mice. The Journal of Nutritional Biochemistry 2023; 119: 109408 doi: 10.1016/j.jnutbio.2023.109408
|
| 28 |
Douglas G. Mashek. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD. Molecular Metabolism 2021; 50: 101115 doi: 10.1016/j.molmet.2020.101115
|
| 29 |
Weiyan Shen, Xingyong Wan, Jiahui Hou, Zhu Liu, Genxiang Mao, Xiaogang Xu, Chaohui Yu, Xudong Zhu, Zhenyu Ju. Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD+ bioavailability protecting against steatohepatitis. Life Medicine 2022; 1(2): 207 doi: 10.1093/lifemedi/lnac031
|
| 30 |
Leonardo Santos, Andrés Benitez-Rosendo, Mariana Bresque, Juliana Camacho-Pereira, Aldo Calliari, Carlos Escande. Sirtuins: The NAD+-Dependent Multifaceted Modulators of Inflammation. Antioxidants & Redox Signaling 2023; 39(16-18): 1185 doi: 10.1089/ars.2023.0295
|
| 31 |
Marwan A. ElBaset, Rana S. Salem, Fairouz Ayman, Nadeen Ayman, Nooran Shaban, Sherif M. Afifi, Tuba Esatbeyoglu, Mahmoud Abdelaziz, Zahraa S. Elalfy. Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis. Antioxidants 2022; 11(11): 2152 doi: 10.3390/antiox11112152
|
| 32 |
Rashad Mogalli, Toshiya Matsukawa, Osamu Shimomura, Hiroko Isoda, Nobuhiro Ohkohchi. Cyanidin-3-glucoside enhances mitochondrial function and biogenesis in a human hepatocyte cell line. Cytotechnology 2018; 70(6): 1519 doi: 10.1007/s10616-018-0242-4
|
| 33 |
Mohammad Borji, Mitra Nourbakhsh, Sayed Mohammad Shafiee, Ali Akbar Owji, Zohreh Abdolvahabi, Zahra Hesari, Davod Ilbeigi, Parvaneh Seiri, Zeynab Yousefi. Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells. Biochemical Genetics 2019; 57(4): 507 doi: 10.1007/s10528-019-09905-5
|
| 34 |
Hassan Farghali, Mighty Kgalalelo Kemelo, Nikolina Kutinová Canová. SIRT1 Modulators in Experimentally Induced Liver Injury. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8765954
|
| 35 |
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
|
| 36 |
Silvano Junior Santini, Cristiana Porcu, Giovanni Tarantino, Fernanda Amicarelli, Clara Balsano. Oleuropein overrides liver damage in steatotic mice. Journal of Functional Foods 2020; 65: 103756 doi: 10.1016/j.jff.2019.103756
|
| 37 |
Sri Jayanti, Libor Vítek, Claudio Tiribelli, Silvia Gazzin. The Role of Bilirubin and the Other “Yellow Players” in Neurodegenerative Diseases. Antioxidants 2020; 9(9): 900 doi: 10.3390/antiox9090900
|
| 38 |
Karl Walter Bock. Aryl hydrocarbon receptor (AHR) functions: Balancing opposing processes including inflammatory reactions. Biochemical Pharmacology 2020; 178: 114093 doi: 10.1016/j.bcp.2020.114093
|
| 39 |
Meng-Ting Ren, Meng-Li Gu, Xin-Xin Zhou, Mo-Sang Yu, Hang-Hai Pan, Feng Ji, Chen-Yan Ding. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis. World Journal of Gastroenterology 2019; 25(38): 5800-5813 doi: 10.3748/wjg.v25.i38.5800
|
| 40 |
Yali Xu, Ting Su, Hricha Mishra, Reiko Ando, Yutaka Furutani, Jun Lu, Muyi Cai, Harukazu Suzuki, Wenkui Yu, Xian-Yang Qin. Corn Oligopeptide Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Sirtuin Signaling Pathway. Journal of Agricultural and Food Chemistry 2024; 72(12): 6360 doi: 10.1021/acs.jafc.3c09058
|
| 41 |
Liu Han, Qilai Long, Shenjun Li, Qixia Xu, Boyi Zhang, Xuefeng Dou, Min Qian, Yannasittha Jiramongkol, Jianming Guo, Liu Cao, Y. Eugene Chin, Eric W.-F. Lam, Jing Jiang, Yu Sun. Senescent Stromal Cells Promote Cancer Resistance through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles. Cancer Research 2020; 80(16): 3383 doi: 10.1158/0008-5472.CAN-20-0506
|
| 42 |
Jonathan R. Deans, Poonamjot Deol, Nina Titova, Sarah H. Radi, Linh M. Vuong, Jane R. Evans, Songqin Pan, Johannes Fahrmann, Jun Yang, Bruce D. Hammock, Oliver Fiehn, Baharan Fekry, Kristin Eckel-Mahan, Frances M. Sladek. HNF4α isoforms regulate the circadian balance between carbohydrate and lipid metabolism in the liver. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1266527
|
| 43 |
Mateusz Wątroba, Ilona Dudek, Marta Skoda, Aleksandra Stangret, Przemysław Rzodkiewicz, Dariusz Szukiewicz. Sirtuins, epigenetics and longevity. Ageing Research Reviews 2017; 40: 11 doi: 10.1016/j.arr.2017.08.001
|
| 44 |
Rafighe Ghiasi, Roya Naderi, Asou Mozaffar, Alireza Alihemmati. The effect of swimming training on oxidative stress, SIRT1 gene expression, and histopathology of hepatic tissue in type 2 diabetic rats. Biologia Futura 2019; 70(3): 167 doi: 10.1556/019.70.2019.21
|
| 45 |
Alexey A. Tinkov, Thuy T. Nguyen, Abel Santamaria, Aaron B. Bowman, Aleksandra Buha Djordjevic, Monica Maria Bastos Paoliello, Anatoly V. Skalny, Michael Aschner. Sirtuins as molecular targets, mediators, and protective agents in metal-induced toxicity. Archives of Toxicology 2021; 95(7): 2263 doi: 10.1007/s00204-021-03048-6
|
| 46 |
|
| 47 |
Veronika A. Prikhodko, Natalia N. Bezborodkina, Sergey V. Okovityi. Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. Biomedicines 2022; 10(2): 274 doi: 10.3390/biomedicines10020274
|
| 48 |
Fatiha Nassir. Role of acetylation in nonalcoholic fatty liver disease: a focus on SIRT1 and SIRT3. Exploration of Medicine 2020; 1(4): 248 doi: 10.37349/emed.2020.00017
|
| 49 |
Janice G. Lozada-Delgado, Carlos A. Torres-Ramos, Sylvette Ayala-Peña. Aging. 2020; : 37 doi: 10.1016/B978-0-12-818698-5.00004-3
|
| 50 |
Decheng Meng, Fengxia Zhang, Wenfei Yu, Xin Zhang, Guoliang Yin, Pengpeng Liang, Yanan Feng, Suwen Chen, Hongshuai Liu. Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver. Diabetes, Metabolic Syndrome and Obesity 2023; : 4043 doi: 10.2147/DMSO.S437865
|
| 51 |
Haibo Dong, Wei Guo, Ruichao Yue, Xinguo Sun, Zhanxiang Zhou. Nuclear Nicotinamide Adenine Dinucleotide Deficiency by Nmnat1 Deletion Impaired Hepatic Insulin Signaling, Mitochondrial Function, and Hepatokine Expression in Mice Fed a High-Fat Diet. Laboratory Investigation 2024; 104(3): 100329 doi: 10.1016/j.labinv.2024.100329
|
| 52 |
Ignazio Barbagallo, Giovanni Li Volti, Marco Raffaele, Alfio Distefano, Rosa Palmeri, Lucia Parafati, Maria Licari, Veronica Zingales, Roberto Avola, Luca Vanella. The effects of olive leaf extract from a Sicilian cultivar in an experimental model of hepatic steatosis. Rendiconti Lincei 2017; 28(4): 643 doi: 10.1007/s12210-017-0649-4
|
| 53 |
Luke He, Ghufran S. Babar, Jacob M. Redel, Sabetha L. Young, Callie E. Chagas, Wayne V. Moore, Yun Yan. Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic. 2021; doi: 10.5772/intechopen.95754
|
| 54 |
Jun Qiang, Xiao-Wen Zhu, Jie He, Yi-Fan Tao, Jin-Wen Bao, Jun-Hao Zhu, Pao Xu. miR-34a Regulates the Activity of HIF-1a and P53 Signaling Pathways by Promoting GLUT1 in Genetically Improved Farmed Tilapia (GIFT, Oreochromis niloticus) Under Hypoxia Stress. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00670
|
| 55 |
F.O. Santos, B.R.O. Correia, T.S. Marinho, Sandra Barbosa-da-Silva, Carlos A. Mandarim-de-Lacerda, Vanessa Souza-Mello. Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice. Molecular and Cellular Endocrinology 2020; 509: 110804 doi: 10.1016/j.mce.2020.110804
|
| 56 |
Mengjie Kong, Yan Peng, Liyan Qiu. Oligochitosan-based nanovesicles for nonalcoholic fatty liver disease treatment via the FXR/miR-34a/SIRT1 regulatory loop. Acta Biomaterialia 2023; 164: 435 doi: 10.1016/j.actbio.2023.04.002
|
| 57 |
Maryam Bazrgar, Pariya Khodabakhsh, Mercedes Prudencio, Fatemeh Mohagheghi, Abolhassan Ahmadiani. The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders. Pharmacological Research 2021; 172: 105805 doi: 10.1016/j.phrs.2021.105805
|
| 58 |
Yunxia Wang, Kongxi Zhu, Weihua Yu, Hongjuan Wang, Lan Liu, Qiong Wu, Shuai Li, Jianqiang Guo. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1. Biochemical and Biophysical Research Communications 2017; 493(1): 227 doi: 10.1016/j.bbrc.2017.09.042
|
| 59 |
Clémence Rives, Anne Fougerat, Sandrine Ellero-Simatos, Nicolas Loiseau, Hervé Guillou, Laurence Gamet-Payrastre, Walter Wahli. Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules 2020; 10(12): 1702 doi: 10.3390/biom10121702
|
| 60 |
Karl Walter Bock. Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammation. Biochemical Pharmacology 2021; 184: 114346 doi: 10.1016/j.bcp.2020.114346
|
| 61 |
Kai Zhang, Anna E. Barry, Ryan Lamm, Keyur Patel, Michelle Schafer, Hien Dang. The role of RNA binding proteins in hepatocellular carcinoma. Advanced Drug Delivery Reviews 2022; 182: 114114 doi: 10.1016/j.addr.2022.114114
|
| 62 |
Xinghong Guo, Kai Liang, Longqing Xia, Xu Zhang, Jinbo Liu, Chuan Wang, Jinquan Li, Xiangzhi Li, Xinguo Hou, Li Chen. Mof plays distinct roles in hepatic lipid metabolism under healthy or non-alcoholic fatty liver conditions. iScience 2023; 26(12): 108446 doi: 10.1016/j.isci.2023.108446
|
| 63 |
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, Carmelina Loguercio, Alessandro Federico. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021; 13(5): 1679 doi: 10.3390/nu13051679
|
| 64 |
Raghu Ramanathan, Ahmad Hassan Ali, Jamal A. Ibdah. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(13): 7280 doi: 10.3390/ijms23137280
|
| 65 |
Jose M. Herranz, Amaya López-Pascual, Alex Clavería-Cabello, Iker Uriarte, M. Ujúe Latasa, Ainara Irigaray-Miramon, Elena Adán-Villaescusa, Borja Castelló-Uribe, Bruno Sangro, María Arechederra, Carmen Berasain, Matías A. Avila, Maite G Fernández-Barrena. Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD. Journal of Physiology and Biochemistry 2023; 79(4): 901 doi: 10.1007/s13105-023-00976-y
|
| 66 |
Thamires Barros Tavares, Izabelle Barcellos Santos, Graziele Freitas de Bem, Dayane Teixeira Ognibene, Ana Paula Machado da Rocha, Roberto Soares de Moura, Angela de Castro Resende, Julio Beltrame Daleprane, Cristiane Aguiar da Costa. Therapeutic effects of açaí seed extract on hepatic steatosis in high-fat diet-induced obesity in male mice: a comparative effect with rosuvastatin. Journal of Pharmacy and Pharmacology 2020; 72(12): 1921 doi: 10.1111/jphp.13356
|
| 67 |
Junli Zhang, Yajuan Zhao, Shuhan Wang, Guixin Li, Keshu Xu. CREBH alleviates mitochondrial oxidative stress through SIRT3 mediating deacetylation of MnSOD and suppression of Nlrp3 inflammasome in NASH. Free Radical Biology and Medicine 2022; 190: 28 doi: 10.1016/j.freeradbiomed.2022.07.018
|
| 68 |
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
|
| 69 |
Yaoxiang Zhu, Ruijue Liu, Zhenglin Shen, Guoqiang Cai. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathway. Life Sciences 2020; 256: 117990 doi: 10.1016/j.lfs.2020.117990
|
| 70 |
Francesca Bonomini, Gaia Favero, Luigi Fabrizio Rodella, Mohammed H. Moghadasian, Rita Rezzani. Melatonin Modulation of Sirtuin-1 Attenuates Liver Injury in a Hypercholesterolemic Mouse Model. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/7968452
|
| 71 |
Decheng Meng, Guoliang Yin, Suwen Chen, Xin Zhang, Wenfei Yu, Linya Wang, Hongshuai Liu, Wenying Jiang, Yuqing Sun, Fengxia Zhang. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway. European Journal of Pharmacology 2024; 977: 176737 doi: 10.1016/j.ejphar.2024.176737
|
| 72 |
J. Samael Rodríguez-Sanabria, Rebeca Escutia-Gutiérrez, Rebeca Rosas-Campos, Juan S. Armendáriz-Borunda, Ana Sandoval-Rodríguez. An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.770504
|
| 73 |
Fatiha Nassir. NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules 2022; 12(6): 824 doi: 10.3390/biom12060824
|
| 74 |
Young‐Eun Cho, Do‐Kyun Kim, Wonhyo Seo, Bin Gao, Seong‐Ho Yoo, Byoung‐Joon Song. Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol‐Inducible Cytochrome P450‐2E1–Mediated Oxidative and Nitrative Stress. Hepatology 2021; 73(6): 2180 doi: 10.1002/hep.30652
|
| 75 |
Peng Wang, Ruikai Li, Yuqi Li, Siwei Tan, Jie Jiang, Huiling Liu, Xiuqing Wei. Berberine alleviates non-alcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice. Gastroenterology Report 2022; 11 doi: 10.1093/gastro/goad032
|
| 76 |
Laura A. Cox, Jeannie Chan, Prahlad Rao, Zeeshan Hamid, Jeremy P. Glenn, Avinash Jadhav, Vivek Das, Genesio M. Karere, Ellen Quillen, Kylie Kavanagh, Michael Olivier. Integrated omics analysis reveals sirtuin signaling is central to hepatic response to a high fructose diet. BMC Genomics 2021; 22(1) doi: 10.1186/s12864-021-08166-0
|
| 77 |
Weiyan Zhang, Yue Sun, Wei Liu, Jinling Dong, Jinglong Chen. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4059
|
| 78 |
Hossein Nikroo, Seyyed Reza Attarzadeh Hosseini, Mehrdad Fathi, Mohammad Ali Sardar, Majid Khazaei. The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats. Physiology & Behavior 2020; 227: 113149 doi: 10.1016/j.physbeh.2020.113149
|
| 79 |
D. Ezhilarasan, M. Najimi. Sirtuin Biology in Medicine. 2021; : 329 doi: 10.1016/B978-0-12-814118-2.00005-7
|
| 80 |
Xu Yang, Anni Lu, Xiao Guan, Tianlei Ying, Jingrong Pan, Mingqian Tan, Jun Lu. An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR). Food Frontiers 2024; doi: 10.1002/fft2.511
|
| 81 |
Pedro Gomes, Sofia D. Viana, Sara Nunes, Anabela P. Rolo, Carlos M. Palmeira, Flávio Reis. The yin and yang faces of the mitochondrial deacetylase sirtuin 3 in age-related disorders. Ageing Research Reviews 2020; 57: 100983 doi: 10.1016/j.arr.2019.100983
|
| 82 |
Xiao Xu, Xiaojie Deng, Yunzhi Chen, Wen Xu, Fen Xu, Hua Liang. SIRT1 mediates nutritional regulation of SREBP-1c-driven hepatic PNPLA3 transcription via modulation of H3k9 acetylation. Genes and Environment 2022; 44(1) doi: 10.1186/s41021-022-00246-1
|
| 83 |
Jiangxue Han, Shunwang Li, Weizhi Wang, Xinhai Jiang, Chao Liu, Lijuan Lei, Yining Li, Ren Sheng, Yuyan Zhang, Yexiang Wu, Jing Zhang, Yuhao Zhang, Yanni Xu, Shuyi Si. SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism. Current Issues in Molecular Biology 2023; 45(6): 5052 doi: 10.3390/cimb45060321
|
| 84 |
Liang Guo, Ying-Ying Guo, Bai-Yu Li, Wan-Qiu Peng, Xin-Xia Chang, Xin Gao, Qi-Qun Tang. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease. Journal of Biological Chemistry 2019; 294(31): 11805 doi: 10.1074/jbc.RA119.008708
|
| 85 |
Ahmed M. Sayed, Emad H.M. Hassanein, Shimaa H. Salem, Omnia E. Hussein, Ayman M. Mahmoud. Flavonoids-mediated SIRT1 signaling activation in hepatic disorders. Life Sciences 2020; 259: 118173 doi: 10.1016/j.lfs.2020.118173
|
| 86 |
Pan Cao, Qian Chen, Chunxia Shi, Maohua Pei, Luwen Wang, Zuojiong Gong. Pinocembrin ameliorates acute liver failure via activating the Sirt1/PPARα pathway in vitro and in vivo. European Journal of Pharmacology 2022; 915: 174610 doi: 10.1016/j.ejphar.2021.174610
|
| 87 |
The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism. Liver Research 2020; 4(2): 94 doi: 10.1016/j.livres.2020.04.001
|
| 88 |
Zehuan Ding, Jian Zhang, Mahua Choudhury. A High-Fat and High-Fructose Diet Exacerbates Liver Dysfunction by Regulating Sirtuins in a Murine Model. Life 2024; 14(6): 729 doi: 10.3390/life14060729
|
| 89 |
Linmeng Han, Chunyu Zhang, Danni Wang, Jiaqi Zhang, Qiqi Tang, Mulin Jun Li, Michael N. Sack, Lingdi Wang, Lu Zhu. Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1. Oncogene 2023; doi: 10.1038/s41388-023-02621-w
|